153 related articles for article (PubMed ID: 11177493)
1. Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility.
Wolff K; Rostami-Hodjegan A; Hay AW; Raistrick D; Tucker G
Addiction; 2000 Dec; 95(12):1771-83. PubMed ID: 11177493
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of methadone in healthy subjects and opiate users.
Wolff K; Rostami-Hodjegan A; Shires S; Hay AW; Feely M; Calvert R; Raistrick D; Tucker GT
Br J Clin Pharmacol; 1997 Oct; 44(4):325-34. PubMed ID: 9354306
[TBL] [Abstract][Full Text] [Related]
3. [Methadone: from pharmacokinetic profile to clinical pharmacology].
Vazquez V; Gury C; Laqueille X
Encephale; 2006; 32(4 Pt 1):478-86. PubMed ID: 17099560
[TBL] [Abstract][Full Text] [Related]
4. Steady-state pharmacokinetics of methadone in opioid addicts.
Wolff K; Hay AW; Raistrick D; Calvert R
Eur J Clin Pharmacol; 1993; 44(2):189-94. PubMed ID: 8453965
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes.
Rostami-Hodjegan A; Wolff K; Hay AW; Raistrick D; Calvert R; Tucker GT
Br J Clin Pharmacol; 1999 Jul; 48(1):43-52. PubMed ID: 10383559
[TBL] [Abstract][Full Text] [Related]
6. The use of levo-alpha-acetylmethadol (LAAM) in methadone patients who have not achieved heroin abstinence.
Borg L; Ho A; Wells A; Joseph H; Appel P; Moody D; Kreek MJ
J Addict Dis; 2002; 21(3):13-22. PubMed ID: 12094997
[TBL] [Abstract][Full Text] [Related]
7. [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
Laqueille X; Launay C; Dervaux A; Kanit M
Encephale; 2009 Jun; 35(3):220-5. PubMed ID: 19540407
[TBL] [Abstract][Full Text] [Related]
8. Altered methadone pharmacokinetics in pregnancy: implications for dosing.
Swift RM; Dudley M; DePetrillo P; Camara P; Griffiths W
J Subst Abuse; 1989; 1(4):453-60. PubMed ID: 2485290
[TBL] [Abstract][Full Text] [Related]
9. Rated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment.
Hiltunen AJ; Beck O; Hjemdahl P; Liljeberg P; Almström U; Brodin K; von Wachenfeldt J; Borg S
Psychopharmacology (Berl); 1999 Apr; 143(4):385-93. PubMed ID: 10367556
[TBL] [Abstract][Full Text] [Related]
10. Changes to methadone clearance during pregnancy.
Wolff K; Boys A; Rostami-Hodjegan A; Hay A; Raistrick D
Eur J Clin Pharmacol; 2005 Nov; 61(10):763-8. PubMed ID: 16261362
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients.
Foster DJ; Somogyi AA; White JM; Bochner F
Br J Clin Pharmacol; 2004 Jun; 57(6):742-55. PubMed ID: 15151520
[TBL] [Abstract][Full Text] [Related]
12. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial.
Strang J; Metrebian N; Lintzeris N; Potts L; Carnwath T; Mayet S; Williams H; Zador D; Evers R; Groshkova T; Charles V; Martin A; Forzisi L
Lancet; 2010 May; 375(9729):1885-95. PubMed ID: 20511018
[TBL] [Abstract][Full Text] [Related]
13. Prescribing methadone for the opiate addict: a problem of dosage conversion.
Johns AR; Gossop M
Drug Alcohol Depend; 1985 Sep; 16(1):61-6. PubMed ID: 4064909
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring for methadone: scanning the horizon.
Wolff K; Strang J
Eur Addict Res; 1999 Mar; 5(1):36-42. PubMed ID: 10085499
[TBL] [Abstract][Full Text] [Related]
15. Cost utility analysis of co-prescribed heroin compared with methadone maintenance treatment in heroin addicts in two randomised trials.
Dijkgraaf MG; van der Zanden BP; de Borgie CA; Blanken P; van Ree JM; van den Brink W
BMJ; 2005 Jun; 330(7503):1297. PubMed ID: 15933353
[TBL] [Abstract][Full Text] [Related]
16. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.
Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F
Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805
[TBL] [Abstract][Full Text] [Related]
17. Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use.
Longshore D; Annon J; Anglin MD; Rawson RA
Addiction; 2005 Aug; 100(8):1131-9. PubMed ID: 16042643
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts.
de Vos JW; Geerlings PJ; van den Brink W; Ufkes JG; van Wilgenburg H
Eur J Clin Pharmacol; 1995; 48(5):361-6. PubMed ID: 8641323
[TBL] [Abstract][Full Text] [Related]
19. [Problems with maintenance therapy in opiate dependence and the clinical importance of methadone].
Wilczek H
Cas Lek Cesk; 1998 Nov; 137(23):725-8. PubMed ID: 9990177
[TBL] [Abstract][Full Text] [Related]
20. Matching of treatment-resistant heroin-dependent patients to medical prescription of heroin or oral methadone treatment: results from two randomized controlled trials.
Blanken P; Hendriks VM; Koeter MW; van Ree JM; van den Brink W
Addiction; 2005 Jan; 100(1):89-95. PubMed ID: 15598196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
